In a move hailed as a significant win for seniors, the Biden administration announced it has successfully negotiated substantial price reductions for 10 of Medicare’s most expensive and widely used prescription drugs. The result of intense negotiations with pharmaceutical giants, the move is expected to deliver billions in savings for both U.S. taxpayers and millions of older Americans who rely on these medications to manage chronic and life-threatening conditions.